ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,930.85
      1.09%
      US Tech 100
      20,836.00
      1.31%
      Dow Jones
      42,840.26
      1.18%
      Brent Oil
      72.72
      0.00%
      Bitcoin
      97,144.49
      -0.06%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NYSE

      6. Penumbra Inc (PEN) Quote

      Penumbra Inc

      Penumbra Inc (PEN)

      Peninsula Energy Ltd
      Pennant International Group Plc
      PBF Energy Inc
      242.54
      -0.98
      (-0.40%)
      Closed December 22 4:00PM
      Delayed by 15 minutes
      242.54
      0.00
      (0.00%)
      After Hours: 7:02PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      242.54
      Bid
      -
      Ask
      -
      Volume
      947,596
      240.56 Day's Range 245.89
      148.00 52 Week Range 277.34
      Market Cap
      9.308B
      Previous Close
      243.52
      Open
      242.00
      Last Trade
      1
      @
      242.14
      Last Trade Time
      Financial Volume
      $ 230,147,094
      VWAP
      242.8747
      Average Volume (3m)
      338,093
      Shares Outstanding
      38,379,199
      Dividend Yield
      -
      PE Ratio
      102.32
      Earnings Per Share (EPS)
      2.37
      Revenue
      1.06B
      Net Profit
      90.95M

      About Penumbra Inc

      Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurova... Penumbra Inc develops and manufactures medical devices for the neurovascular and peripheral vascular markets. Its products are primarily sold to hospitals and are developed for use by specialist physicians. The neurovascular product category contributes to the majority of revenue. Within the neurovascular business, the firm offers products for the neurovascular access, ischemic stroke, neurovascular embolization, and neurosurgical tool markets. In the peripheral vascular business, the firm sells devices related to peripheral embolization and peripheral thrombectomy. Penumbra generates the majority of its revenue in the United States. Show more

      Sector
      Surgical,med Instr,apparatus
      Industry
      Surgical,med Instr,apparatus
      Website
      www.penumbrainc.com
      Headquarters
      Dover, Delaware, USA
      Founded
      -
      Penumbra Inc is listed in the Surgical,med Instr,apparatus sector of the New York Stock Exchange with ticker PEN. The last closing price for Penumbra was $243.52. Over the last year, Penumbra shares have traded in a share price range of $ 148.00 to $ 277.34.

      Penumbra currently has 38,379,199 shares outstanding. The market capitalization of Penumbra is $9.35 billion. Penumbra has a price to earnings ratio (PE ratio) of 102.32.

      Ask ADVFN Intelligence (AI)

      Penumbra (PEN) Options Flow Summary

      PEN Options Flow

      Overall Flow

      Bullish

      Net Premium

      339k

      Calls / Puts

      100.00%

      Buys / Sells

      66.67%

      OTM / ITM

      66.67%

      Sweeps Ratio

      0.00%

      PEN Latest News

      More News

      Form 4 - Statement of changes in beneficial ownership of securities

      December 17 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 17 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 17 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 03 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      December 03 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      December 02 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      November 29 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      November 22 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      November 20 2024
      Edgar (US Regulatory)

      Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference

      Penumbra, Inc. to Present at the Piper Sandler 36th Annual Healthcare Conference PR Newswire ALAMEDA, Calif., Nov. 20, 2024 ALAMEDA, Calif., Nov. 20, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE:...

      November 20 2024
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-9.05-3.59712230216251.59251.74235.7548362353243.9994261CS
      42.541.05833333333240259.27235.7548305282245.91693901CS
      1249.2725.4928338594193.27259.27186.965338093225.54157545CS
      2666.5237.7911600954176.02259.27148403816201.54665777CS
      52-9.56-3.79214597382252.1277.34148369203212.20252533CS
      156-7.15-2.863550803249.69348.67114.865353273219.43702648CS
      26081.450.5150800546161.14348.67114.865347939219.70662895CS

      PEN - Frequently Asked Questions (FAQ)

      What is the current Penumbra share price?
      The current share price of Penumbra is $ 242.54
      How many Penumbra shares are in issue?
      Penumbra has 38,379,199 shares in issue
      What is the market cap of Penumbra?
      The market capitalisation of Penumbra is USD 9.35B
      What is the 1 year trading range for Penumbra share price?
      Penumbra has traded in the range of $ 148.00 to $ 277.34 during the past year
      What is the PE ratio of Penumbra?
      The price to earnings ratio of Penumbra is 102.32
      What is the cash to sales ratio of Penumbra?
      The cash to sales ratio of Penumbra is 8.79
      What is the reporting currency for Penumbra?
      Penumbra reports financial results in USD
      What is the latest annual turnover for Penumbra?
      The latest annual turnover of Penumbra is USD 1.06B
      What is the latest annual profit for Penumbra?
      The latest annual profit of Penumbra is USD 90.95M
      What is the registered address of Penumbra?
      The registered address for Penumbra is 3500 S DUPONT HWY, DOVER, DELAWARE, 19901
      What is the Penumbra website address?
      The website address for Penumbra is www.penumbrainc.com
      Which industry sector does Penumbra operate in?
      Penumbra operates in the SURGICAL,MED INSTR,APPARATUS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      VNCEVince Holding Corp
      $ 4.70
      (69.06%)
      		1.06M
      SRFMSurf Air Mobility Inc
      $ 3.33
      (23.79%)
      		367.21k
      BBBlackBerry Limited
      $ 3.685
      (23.66%)
      		40.27M
      ALURAllurion Technologies Inc
      $ 0.3439
      (22.87%)
      		702.83k
      CLWClearWater Paper Corporation
      $ 30.26
      (22.46%)
      		3.5M
      IIPRInnovative Industrial Properties Inc
      $ 73.50
      (-22.91%)
      		3.15M
      KUKEKuke Music Holding Limited
      $ 0.31
      (-20.51%)
      		61.48k
      NVONovo Nordisk
      $ 85.00
      (-17.83%)
      		53.81M
      CANGCango Inc
      $ 5.08
      (-11.81%)
      		2.44M
      BNEDBarnes and Noble Education Inc
      $ 9.965
      (-10.31%)
      		1.55M
      QBTSD Wave Quantum Inc
      $ 6.638
      (4.21%)
      		124.23M
      PFEPfizer Inc
      $ 26.36
      (2.29%)
      		111.08M
      APOApollo Global Management Inc
      $ 171.03
      (0.83%)
      		94.47M
      TAT&T Inc
      $ 22.75
      (0.80%)
      		88.77M
      FFord Motor Company
      $ 9.885
      (1.49%)
      		87.61M

      PEN Discussion

      View Posts
      @LaughinPaulRyan @LaughinPaulRyan 4 years ago
      ... ALL NEWS IS GOOD? ... $PEN



      CNBC's Scott Wapner reports on why Quintessential Capital Management is shorting Penumbra and why it's questioning the safety of its medical devices.

      👍️0
      @LaughinPaulRyan @LaughinPaulRyan 4 years ago
      QCM legal team filed detailed reports with allegations of misconduct with FDA, SEC and other institutions urging thorough investigation
      Deceptive behavior would point to lack of integrity unworthy of management leading $10bn healthcare company and may explain Jet7 crisis leading to multiple deaths, injuries
      QCM calls on Adam Elsesser, Arani Bose to resign at once if allegations confirmed
      Situation constitutes existential threat to Penumbra’s viability as a public company
      👍️0
      @LaughinPaulRyan @LaughinPaulRyan 4 years ago
      Executive Summary

      Large portion of scientific literature produced by Penumbra appears authored by fake character in sophisticated, multi-year deception
      Fake character seems fabricated by Penumbra’s management attempting to hide involvement in research with significant undisclosed conflicts of interest
      Conflicted research used extensively to market products to healthcare providers, to support FDA applications and to promote stock in IPO
      Legal advisers: behavior, if confirmed, may constitute serious fraud threatening revocation of FDA clearances, SEC enforcement and litigation from clients
      👍️0
      davidsson10 davidsson10 4 years ago
      https://www.qcmfunds.com/penumbra-and-its-killer-catheter/?source=content_type%3Areact%7Cfirst_level_url%3Anews%7Csection%3Amain_content%7Cbutton%3Abody_link
      👍️0
      @LaughinPaulRyan @LaughinPaulRyan 4 years ago
      ... ROFLMFAO ... $PEN

      Penumbra Inc
      Penumbra, Inc. designs, develops, manufactures, and markets medical devices. The Company offers peripheral vascular and neurovascular devices that help patients suffering from stroke and other neurovascular diseases. Penumbra operates in the United States.
      CURRENT PRICE

      PEN:US197.48USD-26.54-11.85%AS OF 10:55 AM EST 12/08/2020
      👍️0
      TREND1 TREND1 9 years ago
      IPO INFO

      http://www.marketwatch.com/tools/ipo-calendar
      👍️0
      TREND1 TREND1 9 years ago
      IPO NOW HAS SYMBOL
      Penumbra PEN
      👍️0
      TREND1 TREND1 9 years ago
      IPO should be out soon.
      no symbol yet.
      👍️0

      Your Recent History

      NYSE
      PEN
      Penumbra
      POLO
      ANYUSDT
      Anyswap
      EU
      ALAMA
      AMA
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads